Dietary isoflavone intake and all‐cause mortality in breast cancer survivors: The Breast Cancer Family Registry

Soy foods possess both antiestrogenic and estrogen‐like properties. It remains controversial whether women diagnosed with breast cancer should be advised to eat more or less soy foods, especially for those who receive hormone therapies as part of cancer treatment.

[1]  S. Carlson,et al.  The Physical Activity Guidelines for Americans , 2018, JAMA.

[2]  Adam D. Seal,et al.  Nutritional Epidemiology. , 2018, Current developments in nutrition.

[3]  Alana D. Steffen,et al.  Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort , 2014, British Journal of Nutrition.

[4]  Raymond J Carroll,et al.  The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans. , 2014, The Journal of nutrition.

[5]  B. Henderson,et al.  The Effects of Soy Consumption before Diagnosis on Breast Cancer Survival: The Multiethnic Cohort Study , 2013, Nutrition and cancer.

[6]  R. Wu,et al.  Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. , 2013, Asian Pacific Journal of Cancer Prevention.

[7]  I. Andrulis,et al.  Accuracy of Self-Reported Breast Cancer Information among Women from the Ontario Site of the Breast Cancer Family Registry , 2012, Journal of cancer epidemiology.

[8]  X. Shu,et al.  Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. , 2012, The American journal of clinical nutrition.

[9]  Hong-Bin Kang,et al.  Positive effects of soy isoflavone food on survival of breast cancer patients in China. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[10]  C. Rock,et al.  Soy Food Consumption and Breast Cancer Prognosis , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[11]  Qingyuan Zhang,et al.  Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy , 2010, Canadian Medical Association Journal.

[12]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[13]  C. Quesenberry,et al.  Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study , 2009, Breast Cancer Research and Treatment.

[14]  A. Leathem,et al.  Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. , 2008, European journal of cancer.

[15]  A. Neugut,et al.  Dietary Flavonoid Intake and Breast Cancer Survival among Women on Long Island , 2007, Cancer Epidemiology Biomarkers & Prevention.

[16]  W. McCaskill-Stevens,et al.  Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. , 2006, Journal of the National Cancer Institute.

[17]  G. Giles,et al.  Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[19]  D O Stram,et al.  Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. , 2000, American journal of epidemiology.

[20]  K. Setchell,et al.  Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.

[21]  L. Qin,et al.  Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies , 2010, Breast Cancer Research and Treatment.